Notes
2017 US dollars
Reference
Sfeir M, et al. Cost-Effectiveness of Ceftazidime-Avibactam Compared to Colistin for Treatment of Carbapenem-Resistant Enterobacteriaceae Bacteremia and Pneumonia. IDWeek 2018 : (plus poster) abstr. 1885, 3 Oct 2018. Available from: URL: https://idsa.confex.com/idsa/2018/webprogram/Paper71006.html
Rights and permissions
About this article
Cite this article
Avibactam/ceftazidime cost effective in USA. PharmacoEcon Outcomes News 816, 6 (2018). https://doi.org/10.1007/s40274-018-5426-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5426-9